UT Health San Antonio spinoff company advancing brain injury drug
Research launched at The University of Texas Health Science Center at San Antonio over a decade ago is nearing a landmark moment.
Astrocyte Pharmaceuticals, a UT Health San Antonio spinoff company founded on technology owned by the University of Texas System Board of Regents, has scored a $3 million award from the Medica l Technology Enterprise Consortium, or MTEC, to fund a Phase I clinical safety study in humans for a drug to treat a variety of brain injuries, including concussion and stroke.
Alamo…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: W. Scott Bailey Source Type: news
More News: Brain | Concussion | Health Management | Neurology | Science | Stroke | Study | Texas University